JNJ-17203212 | Interleukin Related interleukin-related.com

Product Name :
JNJ-17203212

Search keywords :
JNJ-17203212

drugId :
null

Target Vo:
Transient receptor potential cation channel subfamily V member 1

Target Vo Short Name :
TRPV1

Moa_Name:
Vanilloid receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Johnson & Johnson

Active Company_Name :
Johnson & Johnson

Active Indication_Name:
Migraine Disorders

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospholipase C gamma 1 Antibody
Phospholipase C gamma 1 Antibody
Dynactin Subunit 1 Antibody (YA869): Dynactin Subunit 1 Antibody (YA869) is an unconjugated, approximately 142 kDa, mouse-derived, anti-Dynactin Subunit 1 (YA869) monoclonal antibody. Dynactin Subunit 1 Antibody (YA869) can be used for: WB, IP expriments in human background without labeling.

Author: Interleukin Related

Related Posts